Saranac Partners Ltd purchased a new stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the second quarter, HoldingsChannel reports. The firm purchased 24,420 shares of the financial services provider’s stock, valued at approximately $605,000.
A number of other large investors have also added to or reduced their stakes in the stock. Kelleher Financial Advisors acquired a new position in Trupanion in the 2nd quarter valued at $42,000. Parallel Advisors LLC grew its holdings in shares of Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. bought a new position in shares of Trupanion in the fourth quarter worth $64,000. Quantbot Technologies LP bought a new position in shares of Trupanion in the second quarter worth $89,000. Finally, Advisory Services Network LLC acquired a new position in Trupanion in the third quarter valued at about $160,000.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on TRUP shares. Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a report on Wednesday, July 15th. Finally, Stifel Nicolaus increased their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $41.80.
Insider Transactions at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 6,177 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the transaction, the chief financial officer directly owned 2,081 shares in the company, valued at approximately $46,156.58. This trade represents a 74.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the sale, the executive vice president directly owned 78,062 shares in the company, valued at $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 18,294 shares of company stock worth $412,129. Insiders own 5.58% of the company’s stock.
Trupanion Stock Performance
Shares of Trupanion stock opened at $31.10 on Monday. The firm’s 50 day moving average is $26.32 and its 200 day moving average is $26.02. The firm has a market capitalization of $1.36 billion, a PE ratio of 58.68, a price-to-earnings-growth ratio of 2.10 and a beta of 1.39. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $48.48. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. The business had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.22 EPS. Equities research analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Further Reading
- Five stocks we like better than Trupanion
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
